JUMP REPORT
| Avg Daily Volume: 980,597 Market Cap: 14.67B Sector: Services Short Interest: 6.62 |
EARNINGS EXPECTATIONS:
THIS QTR: EPS: .05/share REV: 266.5/M
___________________________________________________________
LAST QTR: EPS: .03/share ACTUAL: .11/share (BEAT)
____________________________________________________________
NEXT QTR: EPS: .O8/share REV: 275.7/M
______________________________________________________
FULL YR: EPS: .24/share REV: 965.4/M
______________________________________________________
*These are the base metrics we will be watching against the actual release numbers
______________________________________________________
BEAT/MISS RECORD: 50% OF THE TIME THEY BEAT ESTIMATES
PRIOR ‘JUMP ZONE’ MOVES (LAST 3 QTRS %) 14.35, -30.13, -7.43
EXPECTED JUMP MOVE: 10%+
Links To Latest News and Headlines
Insiders who purchased US$12m worth of DocuSign, Inc. ( NASDAQ:DOCU ) shares over the past year recouped some of their…
The consumer price index moderated slightly in April, rising 8.2% over the past year on a seasonally adjusted basis. While that indicates some improvement from March, prices are still climbing quickly, and inflation has exceeded the Federal Reserve’s 2% target for fourteen consecutive quarters. Here are two growth stocks worth buying right now.
(Bloomberg) — Software companies that delivered fantastic returns in recent years have lost more than half of their value since hitting peaks last fall.Most Read from BloombergStocks Suffer Steepest Rout in Almost Two Years: Markets WrapWalmart Flashes a Warning Sign to the Entire Consumer EconomyTarget and Walmart’s Deep Pain Could Be Your GainPlotkin Shuts Melvin Hedge Fund Left Reeling by Redditor AttackOz, McCormick Locked in Too-Close-to-Call Pennsylvania RaceLockdown darlings Zoom Video C
DocuSign (DOCU) closed at $75.25 in the latest trading session, marking a +1.02% move from the prior day.
(Bloomberg) — Tiger Global Management was already off to a “very disappointing” first quarter, when it cut some of the biggest tech losers of 2022 from its portfolio and added others.Most Read from BloombergStocks Suffer Steepest Rout in Almost Two Years: Markets WrapWalmart Flashes a Warning Sign to the Entire Consumer EconomyTarget and Walmart’s Deep Pain Could Be Your GainPlotkin Shuts Melvin Hedge Fund Left Reeling by Redditor AttackOz, McCormick Locked in Too-Close-to-Call Pennsylvania Rac
StockJumpers analysis and trade plans are uploaded generally 1 HOUR BEFORE MARKETS CLOSE (3PM EST) for most events.
“I’m sorry, this content is for members only. To access this content, you must log in with your membership credentials – OR if you are not a member yet, visit our registration page here and get signed up Looking forward to having you on-board ASAP”
There is a significant amount of data behind the scenes involved in the analysis and trade plan tab above, that does not get put into the report. Too much information for traders often confuses things – so this is stripped down to only what is needed to make the best possible decision(s) on trading the trajectory.
NOTICE: All data on this site has been published for informational and educational purposes only and does not constitute an offer to sell nor a solicitation of an offer to buy any security which may be referenced here or in our websites. StockJumpers is not an Investment Adviser and relies on the publisher’s exemption as defined in Section 401(f) of the Uniform Securities Act, and provides no personal advice or recommendations. The services and published information contained herein is for non-commercial, educational use and display. StockJumpers and any of its affiliates does not represent that the securities or services discussed are suitable for any investor. You should assume that StockJumpers and or its management has or will take a position in the stock, whether it is stated or not. You are further advised not to rely on any information contained in this report and associated websites in the process of making a fully informed investment decision. Trading is risky and you can lose your investment. For the complete risk disclosure and other legal information please review the full Terms of Use Agreement.